Overview

• Rep. Ro Khanna has introduced a bill to codify President Trump’s Most-Favored-Nation drug pricing executive order into law, aiming to prevent pharmaceutical industry lawsuits and ensure long-term price reductions.
• The legislation would ensure Americans pay no more for prescription drugs than citizens of other developed countries, addressing the current disparity where U.S. consumers pay two to three times more.
• President Trump’s executive order, signed earlier this week, projects drug price reductions of up to 80% and directs federal agencies to eliminate pharmacy benefit managers and enforce price parity.
• Khanna emphasized bipartisan collaboration, urging Republicans to support the bill, and warned of anticipated legal challenges from Big Pharma, which previously overturned similar measures in court.
• The full text of the bill has not yet been released, leaving key implementation details and potential co-sponsor commitments unresolved.